These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8326382)

  • 1. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
    Michelot JM; Moreau MF; Veyre AJ; Bonafous JF; Bacin FJ; Madelmont JC; Bussiere F; Souteyrand PA; Mauclaire LP; Chossat FM
    J Nucl Med; 1993 Aug; 34(8):1260-6. PubMed ID: 8326382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
    Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
    Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
    J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
    Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
    J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
    Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
    J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
    Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
    J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.
    Bacin F; Michelot J; Bonafous J; Veyre A; Moreau MF; Kemeny JL; Chossat F; Bekhechi D
    Acta Ophthalmol Scand; 1998 Feb; 76(1):56-61. PubMed ID: 9541435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
    Moreau MF; Michelot J; Papon J; Bayle M; Labarre P; Madelmont JC; Parry D; Boire JY; Moins N; Seguin H
    Nucl Med Biol; 1995 Aug; 22(6):737-47. PubMed ID: 8535334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiolabelled iodobenzamide for malignant melanoma staging.
    Rodot S; Darcourt J; Bussière F; Lacour JP; Migneco O; Thyss A; Michelot JM; Bonafous JF; Schneider M; Barety M
    Melanoma Res; 1994 Oct; 4(5):307-12. PubMed ID: 7858415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of malignant melanoma with iodine-123 iodoamphetamine.
    Cohen MB; Saxton RE; Lake RR; Cagle L; Graham LS; Nizze A; Yamada LS; Gan M; Bronca G; Greenwell K
    J Nucl Med; 1988 Jul; 29(7):1200-6. PubMed ID: 3392580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
    Henker C; Bida B; Markwardt J; Schlag P
    Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
    Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
    Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.
    Michelot JM; Moreau MF; Labarre PG; Madelmont JC; Veyre AJ; Papon JM; Parry DF; Bonafous JF; Boire JY; Desplanches GG
    J Nucl Med; 1991 Aug; 32(8):1573-80. PubMed ID: 1869982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results.
    Brandau W; Kirchner B; Bartenstein P; Sciuk J; Kamanabrou D; Schober O
    Eur J Nucl Med; 1993 Mar; 20(3):238-43. PubMed ID: 8462613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
    Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
    Chéhadé F; de Labriolle-Vaylet C; Moins N; Moreau MF; Papon J; Labarre P; Galle P; Veyre A; Hindié E
    J Nucl Med; 2005 Oct; 46(10):1701-6. PubMed ID: 16204721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
    Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
    J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.
    Labarre P; Papon J; Moreau MF; Moins N; Bayle M; Veyre A; Madelmont JC
    Melanoma Res; 2002 Apr; 12(2):115-21. PubMed ID: 11930107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-123-IDAB: a new tracer for scintigraphic visualisation of malignant melanoma.
    Lodewijks H; Everaert H; Hennekes R; Bossuyt A
    Bull Soc Belge Ophtalmol; 1996; 263():109-13. PubMed ID: 9396196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of melanoma lesions using ¹³¹I-IMBA obtained by electrophilic substitution of ¹³¹I for metal organic substituent - a preliminary communication.
    Janczak M; Nejc D; Bieńkiewicz M; Płachcińska A; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2010; 13(2):70-5. PubMed ID: 21598230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.